Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.170
+0.010 (0.86%)
At close: May 19, 2026, 4:00 PM EDT
1.180
+0.010 (0.85%)
After-hours: May 19, 2026, 7:45 PM EDT
Bionano Genomics Employees
As of December 31, 2025, Bionano Genomics had 97 total employees, including 95 full-time and 2 part-time employees. The number of employees decreased by 3 or -3.00% compared to the previous year.
Employees
97
Change (1Y)
-3
Growth (1Y)
-3.00%
Revenue / Employee
$296,268
Profits / Employee
-$325,732
Market Cap
12.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 97 | -3 | -3.00% | 95 | 2 |
| Dec 31, 2024 | 100 | -244 | -70.93% | 98 | 2 |
| Dec 31, 2023 | 344 | -61 | -15.06% | 344 | 0 |
| Sep 30, 2023 | 388 | -17 | -4.20% | 388 | 0 |
| Dec 31, 2022 | 405 | 106 | 35.45% | 405 | 0 |
| Dec 31, 2021 | 299 | 152 | 103.40% | 299 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Precision Optics Corporation | 90 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
BNGO News
- 6 days ago - Bionano Reports First Quarter 2026 Results and Provides a Business Update - GlobeNewsWire
- 13 days ago - Bionano Announces Leadership Transition - GlobeNewsWire
- 14 days ago - Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - GlobeNewsWire
- 20 days ago - Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - GlobeNewsWire
- 6 weeks ago - Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - GlobeNewsWire
- 2 months ago - Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 - GlobeNewsWire
- 2 months ago - Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - GlobeNewsWire
- 2 months ago - Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale - GlobeNewsWire